Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells

Journal of Cellular Biochemistry

Volumn 111, Issue 3, 2010, Pages 554-563

  Liu, Yonglei ^a,b   Song, Xianrang ^a   Wang, Xingwu ^a   Wei, Ling ^a   Xiuju, ^a   Shuanghu Yuan, ^a   Liyan Lv, ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Hypoxia Inducible Factor; Intermittent Hypoxia; Lung Cancer; Migration

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; IRRADIATION; LUNG CANCER; LUNG METASTASIS; NUCLEOTIDE SEQUENCE; OXYGEN TENSION; PRIORITY JOURNAL; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANOXIA; APOPTOSIS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; NEOPLASM METASTASIS;

EID: 78651311704     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22739     Document Type: Article

References (32)

1. Ahn GO, Brown M. 2007. Targeting tumors with hypoxia-activated cytotoxins. Front Biosci 12:3483-3501.
2. Brahimi-Horn MC, Chiche J, Pouyssegur J. 2007. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19:223-229.
3. Cairns RA, Kalliomaki T, Hill RP. 2001. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 61:8903-8908.
4. Cairns R, Papandreou I, Denko N. 2006. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 4:61-70.
5. Chan DA, Giaccia AJ. 2007. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 26:333-339.
6. Chaudary N, Hill RP. 2007. Hypoxia and metastasis. Clin Cancer Res 13: 1947-1949.
7. Cooper C, Liu GY, Niu YL, Santos S, Murphy LC, Watson PH. 2004. Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma. Clin Cancer Res 10: 8720-8727.
8. Dewhirst MW. 2007. Intermittent hypoxia furthers the rationale for hypoxiainducible factor-1 targeting. Cancer Res 67:854-855.
9. Fukumura D, Jain RK. 2007. Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize. J Cell Biochem 101: 937-949.
10. Gatenby RA, Smallbone K, Maini PK, Rose F, Averill J, Nagle RB, Worrall L, Gillies RJ. 2007. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer 97:646-653.
11. Gillies RJ, Gatenby RA. 2007. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev 26:311-317.
12. Hunter A, Hendrikse A, Renan M, Abratt R. 2006. Does the tumor microenvironment influence radiation-induced apoptosis? Apoptosis 11:1727-1735.
13. Keith B, Simon MC. 2007. Hypoxia-inducible factors, stem cells, and cancer. Cell 129:465-472.
14. Kizaka-Kondoh S, Inoue M, Harada H, Hiraoka M. 2003. Tumor hypoxia: A target for selective cancer therapy. Cancer Sci 94:1021-1028.
15. Koga T, Endo H, Miyamoto Y, Mukai M, Akira S, Inoue M. 2008. IGFBPs contribute to survival of pancreatic cancer cells under severely hypoxic conditions. Cancer Lett 268:82-88.
16. Liu W, Guo M, Xu YB, Li D, Zhou ZN, Wu YL, Chen Z, Kogan SC, Chen GQ. 2006. Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia. Blood 107:698-707.
17. Mabjeesh NJ, Amir S. 2007. Hypoxia-inducible factor (HIF) in human tumorigenesis. Histol Histopathol 22:559-572.
18. Martinive P, Defresne F, Bouzin C, Saliez J, Lair F, Grégoire V, Michiels C, Dessy C, Feron O. 2006. Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: Implications for anticancer therapies. Cancer Res 66:11736-11744.
19. Mekhail K, Khacho M, Gunaratnam L, Lee S. 2004. Oxygen sensing by H+: Implications for HIF and hypoxic cell memory. Cell Cycle 3:1027-1029.
20. Moeller BJ, Richardson RA, Dewhirst MW. 2007. Hypoxia and radiotherapy: Opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26:241-248.
21. Okunieff P, Fenton B, Chen Y. 2005. Past, present, and future of oxygen in cancer research. Adv Exp Med Biol 566:213-222.
22. Pettersen EO, Bjørhovde I, Søvik A, Edin NF, Zachar V, Hole EO, Sandvik JA, Ebbesen P. 2007. Response of chronic hypoxic cells to low dose-rate irradiation. Int J Radiat Biol 83:331-345.
23. Raghunand N, Gatenby RA, Gillies RJ. 2003. Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol 76: S11-S22.
24. Stadler W. 2007. Chromosomes, hypoxia, angiogenesis, and trial design: A brief history of renal cancer drug development. Clin Cancer Res 13:1630-1633.
25. Thews O, Gassner B, Kelleher DK, Schwerdt G, Gekle M. 2007. Impact of hypoxic and acidic extracellular conditions on cytotoxicity of chemotherapeutic drugs. Adv Exp Med Biol 599:155-161.
26. Vaupel P. 2004. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14:198-206.
27. Weinmann M, Jendrossek V, Gü ner D, Goecke B, Belka C. 2004. Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways. FASEB J 18:1906-1908.
28. Weinmann M, Belka C, Güner D, Goecke B, Mü ller I, Bamberg M, Jendrossek V. 2005. Array-based comparative gene expression analysis of tumor cells with increased apoptosis resistance after hypoxic selection. Oncogene 24:5914-5922.
29. Wouters A, Pauwels B, Lardon F, Vermorken JB. 2007. Review: Implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions. Oncologist 12:690-712.
30. Yao K, Gietema JA, Shida S, Selvakumaran M, Fonrose X, Haas NB, Testa J, O'Dwyer PJ. 2005. In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo. Br J Cancer 93:1356-1363.
31. Zhou J, Schmid T, Schnitzer S, Brüne B. 2006. Tumor hypoxia and cancer progression. Cancer Lett 23:710-721.
32. Zölzer F, Streffer C. 2002. Increased radiosensitivity with chronic hypoxia in four human tumor cell lines. Int J Radiat Oncol Biol Phys 54:910-920.